Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report

Large cell neuroendocrine carcinoma (LCNEC) of the lung with epidermal growth factor receptor (EGFR) mutation is rare, and few cases have been treated with EGFR tyrosine kinase inhibitors (TKIs). We report the treatment of combined LCNEC with adenocarcinoma harboring an EGFR mutation with EGFR-TKIs...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Case Rep Oncol
Autori principali: Muto, Satoshi, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Hashimoto, Yuko, Suzuki, Hiroyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772843/
https://ncbi.nlm.nih.gov/pubmed/33442360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511112
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi